Search results
13 paź 2014 · Intensive Intravenous Infusion of Insulin. In group 1, blood glucose concentrations decreased to the target range within 12 hours of initiation of treatment in 13 of 15 cats. In those cats, it was necessary to reduce the insulin infusion rate to 0.02–0.03 IU/kg/h to avoid hypoglycemia.
20 lut 2015 · For these cats, a short-acting insulin preparation (eg, regular/soluble insulin) is generally given either intramuscularly (IM) or by intravenous infusion. 114 If regular/soluble insulin is not available, it has been suggested that glargine may also be given IM or intravenously (IV), 115 although good data on its efficacy by these routes is ...
4 maj 2021 · A pilot study comparing a protocol using intermittent administration of glargine and regular insulin to a continuous rate infusion of regular insulin in cats with naturally occurring diabetic ketoacidosis. J Vet Emerg Crit Care. 2015; 25:234‐239. [Google Scholar]
Cats with diabetes are approximately six times less sensitive to insulin than normal cats. 16,19 β Cells in healthy cats are able to respond to changing insulin requirements and produce more insulin when the demand is increased. 20 Factors associated with type 2 diabetes impair the ability to secrete insulin. 21 Mechanisms that impair β cells re...
21 lis 2023 · Describe the use of fixed-rate intravenous insulin infusions (FRIs) in cats and dogs with diabetic ketoacidosis (DKA) and determine if this is associated with faster resolution of ketosis compared to variable-rate intravenous insulin infusions (VRIs).
Cats in group 1 (n = 15) received intravenous infusion of insulin with the goal of maintaining blood glucose concentrations at 90-180 mg/dL, for 6 days. Cats in group 2 (n = 15) received subcutaneous injections of insulin glargine (cats ≤4 kg: 0.5-1.0 IU, q12h; >4 kg 1.5-2.0 IU, q12h), for 6 days.
Abstract. in English, French. The use and efficacy of continuous rate infusion (CRI) of regular insulin intravenously for the treatment of feline diabetic ketoacidosis was retrospectively evaluated. The study focused on the rate of glucose decline, time to resolution of inappetence, time to long-term injectable insulin, and length of hospital stay.
